Just over half of patients in a standard therapy group had normal bone mineral density after a mean follow-up of 6 years; this contrasted with 93% of patients in a vitamin D supplementation group.
Supplementation with vitamin D3 in premenopausal women does not have a significant effect on breast density percentage, nor does it reduce breast cancer risk.
Vitamin D and androgen receptor-targeted therapy successfully reduced growth and induced death of cancerous cells in a cell culture model of triple-negative breast cancer.
Higher serum levels of 25-hydroxyvitamin D (25(OH)D) correlated with a reduced risk of cancer in women.
People residing at higher latitudes, who are exposed to lower levels of sunlight/ultraviolet B light and have a higher prevalence of vitamin D deficiency, are at least twice as likely to develop leukemia than equatorial populations.
Dietary supplementation with vitamin D and/or calcium after removal of precancerous colorectal adenomas (polyps) does not reduce risk of developing future adenomas.
In patients with metastatic colorectal cancer treated with chemotherapy plus biologics, increased vitamin D levels have been linked to improved survival, according to information presented at the ASCO 2015 Annual Meeting.
A lower vitamin D levels prior to treatment for follicular lymphoma has been linked to earlier relapse and increased mortality, according to a new study.
Bruce W. Hollis, PhD, discusses the findings from his study on the benefits of increasing vitamin D intake in patients with prostate cancer undergoing active surveillance.
Neither circulating 25-hydroxyvitamin D (25[OH]D) levels nor common variations in vitamin D pathway genes appear to be associated with risk of fatal prostate cancer, according to recent research.
Vitamin D can protect some people with colorectal cancer by ramping up the immune system's vigilance against tumor cells, according to new research.
Patients in a a phase III study with higher vitamin D levels demonstrated better outcomes after treatment for their colorectal cancer with chemotherapy and targeted therapy.
Certain types of cancer patients tended to have lower vitamin D levels
Cancer patients who have higher levels of vitamin D at diagnosis tend to have better survival rates and remain in remission longer than patients who are vitamin D-deficient, according to a new study.
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|